Primary cardiac leiomyosarcoma: an analysis of clinical characteristics and outcome patterns

Asian Cardiovascular & Thoracic Annals
Ji-Gang WangZhi-Min Wei

Abstract

Primary cardiac leiomyosarcoma is an extremely rare entity. There is no accumulated knowledge about the clinical characteristics and therapeutic strategies for this tumor. This study aimed to systematically review the available literature to investigate the clinicoradiologic and clinicopathologic characteristics, treatment, and outcomes in patients with primary cardiac leiomyosarcoma. We identified 79 instances derived from 72 unique reports and carefully analyzed all clinical presentations, imaging, pathology, treatments, and outcomes. The mean age at onset was 48 years. A symptom of obstruction was the most frequent complaint at diagnosis. Routine imaging methods such as echocardiography, computed tomography, and magnetic resonance imaging had high sensitivity in diagnosis. The tumor has a poorer life expectancy than its counterparts in other sites. The 5-year overall survival and recurrence-free survival rates were 25.4% and 14.7%, respectively. Overall survival was affected by age, surgery, and adjunctive chemotherapy or radiotherapy. Our findings suggest that primary cardiac leiomyosarcomas tend to be biologically more aggressive compared to their counterparts in other sites. However, complete resection and adjunctive chem...Continue Reading

References

Oct 1, 1992·Mayo Clinic Proceedings·H D TazelaarC G McGregor
Feb 1, 1992·Internal Medicine·S TakamizawaA Saitoh
Jun 1, 1991·The Annals of Thoracic Surgery·J B PutnamD A Cooley
Jun 1, 1991·The Annals of Thoracic Surgery·M J AntunesL S Rebelo
Dec 1, 1986·The Thoracic and Cardiovascular Surgeon·L v SegesserB Faidutti
Jan 1, 1987·Scandinavian Journal of Thoracic and Cardiovascular Surgery·B SchmekelE Enghoff
Dec 1, 1986·American Heart Journal·J D TalleyC W Sewell
Nov 1, 1967·Cancer·F B Kennedy
May 1, 1981·Acta Pathologica Japonica·T KarasawaK Sato
Jun 1, 1995·The Annals of Thoracic Surgery·M B AndersonS W Jamieson
Jan 1, 1996·The American Journal of Cardiology·K Reynen
Aug 1, 1996·Journal of Pediatric Hematology/oncology·P HanL J Ettinger
May 23, 1997·International Journal of Cardiology·G K DavisD H Roberts
Jun 27, 1997·International Journal of Cardiology·R PessottoA Mazzucco
Mar 21, 1998·European Radiology·E DurandJ Bittoun
Feb 11, 1998·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·C BassoG Thiene
Jan 8, 1999·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·A KornbergB Reichart
Aug 24, 1999·Archives of Pathology & Laboratory Medicine·M R PinsC D Fletcher
Mar 25, 2000·Japanese Circulation Journal·Y HattoriS Sugimura
Aug 16, 2000·Japanese Circulation Journal·K MinakataN Yamada
Oct 20, 2000·Surgery Today·Y HattoriS Sugimura
Dec 2, 2000·The Thoracic and Cardiovascular Surgeon·A M FabriciusF W Mohr
Oct 19, 2001·Japanese Heart Journal·W WillaertM Vanderheyden
Feb 16, 2002·The Thoracic and Cardiovascular Surgeon·J WippermannT Wahlers
Oct 30, 2003·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Betsy J Evans, Marcus P Haw
Apr 2, 2004·The International Journal of Cardiovascular Imaging·Marek OrbanChristian Firschke
Dec 2, 2004·The Thoracic and Cardiovascular Surgeon·A J RastanM Kostelka
Jan 7, 2005·Circulation Journal : Official Journal of the Japanese Circulation Society·Kazunori IshikawaYasuyuki Hosoda
Jan 10, 2006·The Journal of Thoracic and Cardiovascular Surgery·Alessandro MazzolaGaetano Thiene
Sep 29, 2006·Asian Cardiovascular & Thoracic Annals·Michael MalyshevAnton Malyshev
Dec 13, 2006·Cancer·Catarina SvarvarUNKNOWN Scandinavian Sarcoma Group Leiomyosarcoma Working Group
Jan 31, 2007·Circulation·Seth GoldbargSamin Sharma
Jul 22, 2008·The Annals of Thoracic Surgery·Derek D Muehrcke, Keith Justice

❮ Previous
Next ❯

Citations

Feb 26, 2016·Heart, Lung & Circulation·Ji-Gang WangXiu-Ping Liu
Apr 25, 2017·Rare Tumors·Ruben Blachman-BraunJesús Octavio Martínez-Reding
Jun 4, 2020·Therapeutic Advances in Medical Oncology·Milena UrbiniMaristella Saponara
Jun 10, 2021·Türk göğüs kalp damar cerrahisi dergisi·Mehmet Akif ÖnalanErsin Erek
Nov 15, 2021·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Joseph J MaleszewskiFabio Tavora

❮ Previous
Next ❯

Software Mentioned

Prism
GraphPad
Excel

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.